Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 4, 1997, Pages 897-906

  Constine, Louis S ^a   Schwartz, Ronald G ^a   Savage, Duncan E ^a   King, Vernon ^a   Muhs, Ann ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Hodgkin's disease; Left ventricular ejection fraction; Myocardial infarction; Myocardial perfusion imaging; Radiation induced heart disease; Sestamibi; Thallium

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART DEATH; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFUSION; HODGKIN DISEASE; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; RADIATION INJURY; SURVIVAL TIME;

ADOLESCENT; ADULT; CHILD; DIASTOLE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE VOLUME; SURVIVORS; VENTRICULAR FUNCTION, LEFT;

EID: 0030724403     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00467-7     Document Type: Article

References (37)

1. Annest, L.; Anderson, R.; Li, W.; Haferman, M. Coronary artery disease following mediastinal radiation therapy. J. Thorac. Cardiovasc. Surg. 85:257-263; 1983.
2. Blumenthal, R. S.; Becker, D. M.; Moy, T. F.; Coresh, J.; Wilder, L. B.; Becker, L. C. Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population. Circulation 93:915-923; 1996.
3. Boivin, J.; Hutchinson, G.; Lubin, J.; Mauch, P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69:1241-1247; 1992.
4. Brown, K. A. Prognostic value of thallium-201 myocardial perfusion imaging: A diagnostic tool comes of age. Circulation 83:363-381; 1991.
5. Burns, R.; Bar-Sholomo, B.; Druck, M.; Herman, J.; Gilbert, B.; Perrault, D.; McLaughlin, P. Detection of radiation cardiomyopathy by gated radionuclide angiography. Am. J. Med. 74:297-302; 1983.
6. Cohn, K.; Stewart, J.; Fajardo, L.; Hancock, E. Heart disease following irradiation. Medicine 46:281-298; 1967.
7. Corn, B.; Trock, B.; Goodman, R. Irradiation-related ischemic heart disease. J. Clin. Oncol. 8:741-750; 1990.
8. Cuocolo, A.; Page, L.; Ricciardelli, B. Identification of viable myocardium in patients with chronic coronary artery disease: Comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J. Nucl. Med. 33: 505-522; 1992.
9. Dilsizian, V.; Rocco, T.; Freedman, N.; Leon, M.; Bonow, R. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N. Engl. J. Med. 323:141-146; 1990.
10. Dunsmore, L.; LoPonte, M.; Dunsmore, R. Radiation-induced coronary artery disease. J. Am. Coll. Cardiol. 8:239-244; 1986.
11. Fajardo, L. Radiation-induced coronary artery disease. Chest 71:563-564; 1977.
12. Fajardo, L.; Stewart, J. Radiation-induced heart disease. Human and experiemental observations. In: Bistow, M. R., ed. Drug-induced heart disease. Amsterdam: Elsevier, North-Holland Biomedical Press; 1980:241-260.
13. Fajardo, F.; Stewart, J.; Cohn. K. Morphology of radiation-induced heart disease. Arch. Pathol. 86:512-519; 1968.
14. Glanzmann, C.; Huguenin, P.; Lutolf, U.; Maire, R.; Jenni, R.; Gumppenberg, V. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother. Oncol. 30:43-54; 1994.
15. Gomez, G.; Park, J.; Panahon, A.; Parthasarathy, K.; Pearce, J.; Reese, P.; Bakshi, S.; Henderson, E. Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease. Cancer Treat. Rep. 67:1099-1103; 1983.
16. Gottdiener, J.; Katin, M.; Borer, J.; Bacharach, S.; Green, M. Late cardiac effects of mediastinal irradiation. N. Engl. J. Med. 308:569-572; 1983.
17. Hachamovitch, R.; Berman, D. S.; Kiat, H.; Cohen, I.; Cabico, J. A.; Friedman, J.; Diamond, G. A. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Incremental prognostic value and use in risk stratification. Circulation 93:905-914; 1996.
18. Hancock, S.; Donaldson, S.; Hoppe, R. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J. Clin. Oncol. 11:1208-1215; 1993.
19. Hancock, S.; Tucker, M.; Hoppe, R. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949-1955; 1993.
20. Iskandrian, A. S. Comparison of the treadmill exercise score and single-photon emission computed tomographic thallium imaging in risk assessment. J. Nuclear Cardiol. 1:144-149; 1994.
21. King, V.; Constine, L.; Clark, D.; Schwartz, R.; Muhs, A.; Henzler, M.; Hutson, A.; Rubin, P. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 36:881-889; 1996.
22. Ladenheim, M. L.; Pollock, B. H.; Rozanski, A.; Berman, D. S.; Staniloff, H. M.; Forrester, J. S.; Diamond, G. A. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J. Am. Coll. Cardiol. 7:464-471; 1986.
23. Leach, J. Effect of roentgen therapy on the heart. Arch. Intern. Med. 72:715-745; 1943.
24. Morgan, G.; Freeman, A.; McLean, R.; Jarvie, B.; Giles, R. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 11:1925-1931; 1985.
25. Palos, B.; Kaplan, H.; Karzmark, C. The use of thin lung shields to deliver limited whole-lung irradiation during mantle-field treatment of Hodgkin's disease. Radiology 101:441-442; 1971.
26. Pierga, J.-Y.; Maunoury, C.; Valette, H.; Socie, G.; Girinski, T.; Tchernia, G.; Henry-Amar, M.; Desgrez, A.; Cosset, J.-M. Follow-up Thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 25:871-976; 1993.
27. Pihkala, J.; Saarinen, U.; Lundstrom, U.; Virtanen, K.; Virkola, K.; Siimes, M.; Pesonen, E. Myocardial function in children and adolescents after therapy with antracyclines and chest irradiation. Eur. J. Cancer 32A:97-103; 1996.
28. Pohost, G.; Alpert, N.; Ingwall, J.; Strauss, H. Thallium redistribution: Mechanisms and clinical utility. Semin. Nucl. Med. 10:70-93; 1980.
29. Savage, D.; Constine, L.; Schwartz, D.; Rubin, P. Radiation effects on left ventricular function and myocardial perfusion in long term survivors of Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 19:721-727; 1990.
30. Schwartz, R. G.; McKenzie, W. B.; Alexander, J.; Sager, P.; D'Souza, A.; Manatunga, A.; Schwartz, P. E.; Surkin, L. A.; Setaro, J.; Wackers, F. J. Th.; Zaret, B. L. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: A seven year experience using serial radionuclide angiocardiography. Am. J. Med. 82:1109-1118; 1987.
31. Schwartz, R. G.; Thompson, C.; Mixon, L.; Eckdahl, J. M.; Burns, G. Gated SPECT analysis with 3-D wall parameterization method: Accurate and reproducible evaluation of left ventricular volumes and ejection fraction. Circulation 92:1-449; 1995.
32. Soufer, R.; Wohlgelernter, D.; Vita, N.; Amuchestegui, M.; Sostman, H.; Berger, H.; Zaret, B. Intact systolic left ventricular function in clinical congestive heart failure. Am. J. Cardiol. 55:1032-1036; 1985.
33. Stewart, J.; Fajardo, L. Cancer and coronary artery disease. Int. J. Radiat. Oncol. Biol. Phys. 4:915-916; 1978.
34. Stewart, J.; Fajardo, L. Radiation-induced heart disease: an update. Prog. Cardiovasc. Dis. 27:173-194; 1984.
35. Stewart, J.; Fajardo, L.; Gilette, S.; Constine, L. Radiation injury to the heart. Int. J. Radiat. Oncol. Biol. Phys. 31:1205-1211; 1995.
36. Wackers, F.; Berger, H.; Johnstone, D.; Goldman, L.; Reduto, L.; Langou, R.; Gottschalk, A.; Zaret, B. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: Validation of the technique and assessment of variability. Am. J. Cardiol. 43:1159-1166; 1979.
37. Wackers, F.; Fetterman, R.; Mattera, J.; Clements, J. Quantitative planar thallium-201 stress scintigraphy: A critical evaluation of the method. Semin. Nucl. Med. 15:46-66; 1985.